Alserawan, L.; Mulet, M.; Anguera, G.; Riudavets, M.; Zamora, C.; Osuna-Gómez, R.; Serra-López, J.; Barba JoaquÃn, A.; Sullivan, I.; Majem, M.;
et al. Kinetics of IFNγ-Induced Cytokines and Development of Immune-Related Adverse Events in Patients Receiving PD-(L)1 Inhibitors. Cancers 2024, 16, 1759.
https://doi.org/10.3390/cancers16091759
AMA Style
Alserawan L, Mulet M, Anguera G, Riudavets M, Zamora C, Osuna-Gómez R, Serra-López J, Barba JoaquÃn A, Sullivan I, Majem M,
et al. Kinetics of IFNγ-Induced Cytokines and Development of Immune-Related Adverse Events in Patients Receiving PD-(L)1 Inhibitors. Cancers. 2024; 16(9):1759.
https://doi.org/10.3390/cancers16091759
Chicago/Turabian Style
Alserawan, Leticia, Maria Mulet, Geòrgia Anguera, Mariona Riudavets, Carlos Zamora, Rubén Osuna-Gómez, Jorgina Serra-López, Andrés Barba JoaquÃn, Ivana Sullivan, Margarita Majem,
and et al. 2024. "Kinetics of IFNγ-Induced Cytokines and Development of Immune-Related Adverse Events in Patients Receiving PD-(L)1 Inhibitors" Cancers 16, no. 9: 1759.
https://doi.org/10.3390/cancers16091759
APA Style
Alserawan, L., Mulet, M., Anguera, G., Riudavets, M., Zamora, C., Osuna-Gómez, R., Serra-López, J., Barba JoaquÃn, A., Sullivan, I., Majem, M., & Vidal, S.
(2024). Kinetics of IFNγ-Induced Cytokines and Development of Immune-Related Adverse Events in Patients Receiving PD-(L)1 Inhibitors. Cancers, 16(9), 1759.
https://doi.org/10.3390/cancers16091759